Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2026)
Rapid Micro Biosystems (RPID) posted Asset Writedowns and Impairment of $695000.0 for Q4 2025, up 62.0% sequentially from $429000.0 in Q3 2025, and up 892.86% YoY from $70000.0 in Q4 2024.
Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $695000.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 892.86% year-over-year to $695000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $908000.0 (up 175.15% YoY) and the FY2025 annual result came in at $1.1 million, up 1103.16% from the prior year.
- Asset Writedowns and Impairment rose to $695000.0 in Q4 2025 per RPID's latest filing, from $429000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $695000.0 in Q4 2025 and troughed at -$216000.0 in Q2 2025.
- A 5-year average of $135000.0 and a median of $59500.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 2733.33% in 2022, down 568.75% in 2022.
- Over 5 years, Asset Writedowns and Impairment stood at $16000.0 in 2021, then surged by 568.75% to $107000.0 in 2022, then sank by 68.22% to $34000.0 in 2023, then jumped by 105.88% to $70000.0 in 2024, then jumped by 892.86% to $695000.0 in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $695000.0, $429000.0, and -$216000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Dec 31, 2025 | 695,000.00 |
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | -216,000.00 |
| Jun 30, 2025 | -216,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Sep 30, 2022 | 170,000.00 |